Related Experiment Video
Updated: May 24, 2025
09:04
Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
Published on: September 10, 2018
9.6K
Drug safety in pregnancy.
Debra Kennedy1,2,3, Ronald Batagol1,2,3
1Royal Hospital for Women, Sydney.
Australian Prescriber
|March 5, 2025
Summary
Drug safety during pregnancy is crucial, as timing of exposure impacts fetal development. Limited data exists, necessitating careful benefit-risk assessment for pregnant patients.
Area of Science:
- Pharmacology
- Obstetrics
- Teratology
Background:
- Drug exposure during pregnancy poses risks to fetal development.
- Limited data on drug safety in pregnancy due to trial exclusion and study challenges.
- Balancing maternal treatment benefits against fetal risks is essential.
Purpose of the Study:
- To highlight the impact of drug exposure timing on fetal development.
- To address the paucity of data on drug safety in pregnancy.
- To evaluate existing drug categorization systems for pregnancy.
Main Methods:
- Review of existing literature on drug effects during pregnancy.
- Analysis of challenges in clinical trials and epidemiological studies.
- Comparative assessment of international drug safety categorization systems.
Main Results:
- Timing of drug exposure is critical for fetal impact.
- Significant data gaps exist regarding maternal and fetal drug safety.
- Current drug categorization systems, like Australia's, have limitations.
Conclusions:
- Individualized benefit-risk assessment is vital for prescribing drugs in pregnancy.
- Improvements in drug safety data and categorization systems are needed.
- Evidence-based resources are crucial for healthcare professionals and consumers.
More Related Videos
05:25Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
152
15:27Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development
Published on: July 13, 2014
14.6K
Related Concept Videos
01:07Teratogenicity
2.3K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.3K
01:19Pharmacovigilance
764
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
764
01:25Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
01:23Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
217
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
217
01:21Factors Affecting Drug Response: Overview
1.8K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.8K
01:28Preclinical Development: Overview
4.2K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.2K